Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries-Insights from the REALISM Study.

Autor: Bidar F; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France.; Anesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.; Immunology Laboratory, Hopital E. Herriot, Hospices Civils de Lyon, 69437 Lyon, France., Bodinier M; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France., Venet F; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France.; Immunology Laboratory, Hopital E. Herriot, Hospices Civils de Lyon, 69437 Lyon, France.; NLRP3 Inflammation and Immune Response to Sepsis Team, Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, 69003 Lyon, France., Lukaszewicz AC; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France.; Anesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France., Brengel-Pesce K; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France., Conti F; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France., Quemeneur L; Sanofi Pasteur, Sanofi 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Leissner P; BIOASTER, 40 Avenue Tony Garnier, 69007 Lyon, France., Tan LK; GSK, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK., Textoris J; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France., Rimmelé T; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France.; Anesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France., Monneret G; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Univeristé Lyon 1, 69003 Lyon, France.; Immunology Laboratory, Hopital E. Herriot, Hospices Civils de Lyon, 69437 Lyon, France., On Behalf Of The Realism Study Group

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Dec 24; Vol. 11 (1). Date of Electronic Publication: 2021 Dec 24.